Cargando…

Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII

At sites of vascular damage, factor VIII (fVIII) is proteolytically activated by thrombin and binds to activated platelet surfaces with activated factor IX (fIXa) to form the intrinsic “tenase” complex. Previous structural and mutational studies of fVIII have identified the C1 and C2 domains in bind...

Descripción completa

Detalles Bibliográficos
Autores principales: Peters, Shaun C., Childers, Kenneth C., Mitchell, Corbin E., Avery, Nathan G., Reese, Steven S., Mitchell, Cristopher, Wo, Serena W., Swanson, Christopher D., Brison, Caileen M., Spiegel, P. Clint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643838/
https://www.ncbi.nlm.nih.gov/pubmed/36387287
http://dx.doi.org/10.3389/fmolb.2022.1040106
_version_ 1784826607775514624
author Peters, Shaun C.
Childers, Kenneth C.
Mitchell, Corbin E.
Avery, Nathan G.
Reese, Steven S.
Mitchell, Cristopher
Wo, Serena W.
Swanson, Christopher D.
Brison, Caileen M.
Spiegel, P. Clint
author_facet Peters, Shaun C.
Childers, Kenneth C.
Mitchell, Corbin E.
Avery, Nathan G.
Reese, Steven S.
Mitchell, Cristopher
Wo, Serena W.
Swanson, Christopher D.
Brison, Caileen M.
Spiegel, P. Clint
author_sort Peters, Shaun C.
collection PubMed
description At sites of vascular damage, factor VIII (fVIII) is proteolytically activated by thrombin and binds to activated platelet surfaces with activated factor IX (fIXa) to form the intrinsic “tenase” complex. Previous structural and mutational studies of fVIII have identified the C1 and C2 domains in binding to negatively charged membrane surfaces through β-hairpin loops with solvent-exposed hydrophobic residues and a ring of positively charged basic residues. Several hemophilia A-associated mutations within the C domains are suggested to disrupt lipid binding, preventing formation of the intrinsic tenase complex. In this study, we devised a novel platform for generating recombinant C1, C2, and C1C2 domain constructs and performed mutagenesis of several charged residues proximal to the putative membrane binding region of each C domain. Binding measurements between phosphatidylserine (PS)-containing lipid membrane surfaces and fVIII C domains demonstrated an ionic strength dependence on membrane binding affinity. Mutations to basic residues adjacent to the surface-exposed hydrophobic regions of C1 and C2 differentially disrupted membrane binding, with abrogation of binding occurring for mutations to conserved arginine residues in the C1 (R2163) and C2 (R2320) domains. Lastly, we determined the X-ray crystal structure of the porcine fVIII C2 domain bound to o-phospho-L-serine, the polar headgroup of PS, which binds to a basic cleft and makes charge-charge contact with R2320. We conclude that basic clefts in the fVIII C domains bind to PS-containing membranes through conserved arginine residues via a C domain modularity, where each C domain possesses modest electrostatic-dependent affinity and tandem C domains are required for high affinity binding.
format Online
Article
Text
id pubmed-9643838
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96438382022-11-15 Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII Peters, Shaun C. Childers, Kenneth C. Mitchell, Corbin E. Avery, Nathan G. Reese, Steven S. Mitchell, Cristopher Wo, Serena W. Swanson, Christopher D. Brison, Caileen M. Spiegel, P. Clint Front Mol Biosci Molecular Biosciences At sites of vascular damage, factor VIII (fVIII) is proteolytically activated by thrombin and binds to activated platelet surfaces with activated factor IX (fIXa) to form the intrinsic “tenase” complex. Previous structural and mutational studies of fVIII have identified the C1 and C2 domains in binding to negatively charged membrane surfaces through β-hairpin loops with solvent-exposed hydrophobic residues and a ring of positively charged basic residues. Several hemophilia A-associated mutations within the C domains are suggested to disrupt lipid binding, preventing formation of the intrinsic tenase complex. In this study, we devised a novel platform for generating recombinant C1, C2, and C1C2 domain constructs and performed mutagenesis of several charged residues proximal to the putative membrane binding region of each C domain. Binding measurements between phosphatidylserine (PS)-containing lipid membrane surfaces and fVIII C domains demonstrated an ionic strength dependence on membrane binding affinity. Mutations to basic residues adjacent to the surface-exposed hydrophobic regions of C1 and C2 differentially disrupted membrane binding, with abrogation of binding occurring for mutations to conserved arginine residues in the C1 (R2163) and C2 (R2320) domains. Lastly, we determined the X-ray crystal structure of the porcine fVIII C2 domain bound to o-phospho-L-serine, the polar headgroup of PS, which binds to a basic cleft and makes charge-charge contact with R2320. We conclude that basic clefts in the fVIII C domains bind to PS-containing membranes through conserved arginine residues via a C domain modularity, where each C domain possesses modest electrostatic-dependent affinity and tandem C domains are required for high affinity binding. Frontiers Media S.A. 2022-10-26 /pmc/articles/PMC9643838/ /pubmed/36387287 http://dx.doi.org/10.3389/fmolb.2022.1040106 Text en Copyright © 2022 Peters, Childers, Mitchell, Avery, Reese, Mitchell, Wo, Swanson, Brison and Spiegel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Molecular Biosciences
Peters, Shaun C.
Childers, Kenneth C.
Mitchell, Corbin E.
Avery, Nathan G.
Reese, Steven S.
Mitchell, Cristopher
Wo, Serena W.
Swanson, Christopher D.
Brison, Caileen M.
Spiegel, P. Clint
Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title_full Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title_fullStr Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title_full_unstemmed Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title_short Stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem C domains of blood coagulation factor VIII
title_sort stable binding to phosphatidylserine-containing membranes requires conserved arginine residues in tandem c domains of blood coagulation factor viii
topic Molecular Biosciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643838/
https://www.ncbi.nlm.nih.gov/pubmed/36387287
http://dx.doi.org/10.3389/fmolb.2022.1040106
work_keys_str_mv AT petersshaunc stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT childerskennethc stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT mitchellcorbine stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT averynathang stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT reesestevens stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT mitchellcristopher stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT woserenaw stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT swansonchristopherd stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT brisoncaileenm stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii
AT spiegelpclint stablebindingtophosphatidylserinecontainingmembranesrequiresconservedarginineresiduesintandemcdomainsofbloodcoagulationfactorviii